Search Results - "Lee, A.R.Y.B."

IDF23-0381 Improving Diabetic Wound Healing Outcomes with Topical Growth Factor Therapies: Systematic Review and Network Meta-Analysis of Randomised-controlled Trials by Wong, A.Y.W., Hooi, N.M.F., Yeo, B.S.Y., Sultana, R., Bee, Y.M., Lee, A.R.Y.B., Tay, S.M.

Get full text

Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes by Sundar, R., Chia, D.K.A., Zhao, J.J., Lee, A.R.Y.B., Kim, G., Tan, H.L., Pang, A., Shabbir, A., Willaert, W., Ma, H., Huang, K.K., Hagihara, T., Tan, A.L.K., Ong, C.-A.J., Wong, J.S.M., Seo, C.J., Walsh, R., Chan, G., Cheo, S.W., Soh, C.C.C., Callebout, E., Geboes, K., Ng, M.C.H., Lum, J.H.Y., Leow, W.Q., Selvarajan, S., Hoorens, A., Ang, W.H., Pang, H., Tan, P., Yong, W.P., Chia, C.S.L., Ceelen, W., So, J.B.Y.

“…Pressurized intraperitoneal aerosol chemotherapy-oxaliplatin (PIPAC-OX) induces direct DNA damage and immunogenic cell death in patients with gastric cancer…”
Get full text